Literature DB >> 25906693

MicroRNA-494 inhibition protects nucleus pulposus cells from TNF-α-induced apoptosis by targeting JunD.

Tao Wang1, Pengfei Li1, Xinlong Ma2, Peng Tian3, Chao Han3, Jiacheng Zang3, Jingbo Kong3, Hongliang Yan3.   

Abstract

BACKGROUND: Human nucleus pulposus cell (HNPC) apoptosis plays an important role in the development of intervertebral disc degeneration (IVDD). Our previous research revealed that among all of the dysregulated microRNAs in the degenerated nucleus pulposus tissues of patient with IVDD, miRNA-494 (miR-494) is the most significantly increased. However, the influence of miR-494 HNPC apoptosis has not been confirmed.
OBJECTIVE: This study was designed to evaluate the effect of miR-494 on the HNPC apoptosis induced by TNF-α and to explore the possible mechanism of this process.
METHODS: First, HNPCs were stimulated with TNF-α at different concentrations (0 ng/ml, 10 ng/ml, 50 ng/ml, or 100 ng/ml) for 0 h, 8 h, 16 h, or 24 h. Annexin V-PE/7-AAD assays and real-time quantitative PCR were used to detect the cell apoptosis rates and miR-494 expression. Second, we successfully knocked down endogenous miR-494 in HNPCs via lentiviral antigomiR-494 vector infection and then stimulated with TNF-α (100 ng/ml, 16 h). The rates of apoptosis and miR-494 expression were then detected again. Additionally, a dual-luciferase reporter assay and western blotting were used to determine whether JunD is a target of miR-494. Finally, western blotting was used to analyze the expression of cytochrome C.
RESULTS: We found that the rate of apoptosis increased with concentration, time (p < 0.05) and miR-494 expression (p < 0.05). The rate of apoptosis in the 100 ng/ml, 16 h group appeared to be suitable. After transfection, the apoptosis rate and miR-494 expression were significantly decreased in the antigomiR-494+TNF-α group compared to the controls (p < 0.05). We also revealed that JunD is a target of miR-494. Western blotting analysis demonstrated that treatment with the lentiviral antigomiR-494 vector resulted in increased expression of JunD (p < 0.05) and decreased expression of cytochrome C (p < 0.05).
CONCLUSION: These results indicated that miR-494 is a novel regulator of HNPC apoptosis induced by TNF-α. The knock-out of miR-494 expression protected the HNPCs from apoptosis via the up-regulation of JunD, which was possibly mediated via cytochrome C apoptotic signaling. These findings suggest that the miR-494/JunD signaling pathway might represent a novel therapeutic target for the prevention of IVDD.
Copyright © 2015 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Apoptosis; Intervertebral disc degeneration; JunD; MicroRNA; TNF-α

Mesh:

Substances:

Year:  2015        PMID: 25906693     DOI: 10.1016/j.biochi.2015.04.011

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  28 in total

1.  Mesenchymal stem cells-derived exosomes ameliorate nucleus pulposus cells apoptosis via delivering miR-142-3p: therapeutic potential for intervertebral disc degenerative diseases.

Authors:  Lifan Zhu; Yuhui Shi; Ling Liu; Huan Wang; Pengcheng Shen; Huilin Yang
Journal:  Cell Cycle       Date:  2020-06-17       Impact factor: 4.534

2.  * CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments.

Authors:  Niloofar Farhang; Jonathan M Brunger; Joshua D Stover; Pratiksha I Thakore; Brandon Lawrence; Farshid Guilak; Charles A Gersbach; Lori A Setton; Robby D Bowles
Journal:  Tissue Eng Part A       Date:  2017-02-28       Impact factor: 3.845

3.  Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration.

Authors:  Niloofar Farhang; Matt Ginley-Hidinger; Kristofer C Berrett; Jason Gertz; Brandon Lawrence; Robby D Bowles
Journal:  Hum Gene Ther       Date:  2019-07-17       Impact factor: 5.695

4.  Bacterial and cytokine mixtures predict the length of gestation and are associated with miRNA expression in the cervix.

Authors:  Alison P Sanders; Chris Gennings; Katherine Svensson; Valeria Motta; Adriana Mercado-Garcia; Maritsa Solano; Andrea A Baccarelli; Martha M Tellez-Rojo; Robert O Wright; Heather H Burris
Journal:  Epigenomics       Date:  2016-12-12       Impact factor: 4.778

5.  Ethyl pyruvate inhibits LPS induced IPEC-J2 inflammation and apoptosis through p38 and ERK1/2 pathways.

Authors:  Na Dong; Xinyao Xu; Chenyu Xue; Chensi Wang; Xinran Li; Chongpeng Bi; Anshan Shan
Journal:  Cell Cycle       Date:  2019-09-01       Impact factor: 4.534

6.  Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration.

Authors:  Xiaofei Cheng; Guoying Zhang; Liang Zhang; Ying Hu; Kai Zhang; Xiaojiang Sun; Changqing Zhao; Hua Li; Yan Michael Li; Jie Zhao
Journal:  J Cell Mol Med       Date:  2017-08-14       Impact factor: 5.310

7.  MicroRNA-494 promotes apoptosis and extracellular matrix degradation in degenerative human nucleus pulposus cells.

Authors:  Liang Kang; Cao Yang; Yu Song; Kangcheng Zhao; Wei Liu; Wenbin Hua; Kun Wang; Ji Tu; Shuai Li; Huipeng Yin; Yukun Zhang
Journal:  Oncotarget       Date:  2017-04-25

8.  The inflammatory cytokine TNF-α promotes the premature senescence of rat nucleus pulposus cells via the PI3K/Akt signaling pathway.

Authors:  Pei Li; Yibo Gan; Yuan Xu; Lei Song; Liyuan Wang; Bin Ouyang; Chengmin Zhang; Qiang Zhou
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

Review 9.  Role of microRNAs in intervertebral disc degeneration (Review).

Authors:  Fengguang Yang; Jizu Wang; Zhixin Chen; Yuping Yang; Wenhui Zhang; Shifang Guo; Qingshan Yang
Journal:  Exp Ther Med       Date:  2021-06-10       Impact factor: 2.447

10.  miR-494 Contributes to Estrogen Protection of Cardiomyocytes Against Oxidative Stress via Targeting (NF-κB) Repressing Factor.

Authors:  Zhi-Ping Tang; Wei Zhao; Jian-Kui Du; Xin Ni; Xiao-Yan Zhu; Jian-Qiang Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.